To understand how insulin resistance contributes to the development of CVD in the context of MASLD, it is important to understand which tissues progressively become more resistant to insulin and how they contribute to the manifestations of MASLD. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.